title: Why are patients with chronic myeloid leukaemia (non-)adherent?
authors.forename: I
authors.initials: I
authors.lastname: Abraham
authors.forename: K
authors.initials: K
authors.lastname: MacDonald
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides; D005221:Fatigue; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D057226:Information Seeking Behavior; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D055118:Medication Adherence; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D011788:Quality of Life; D012944:Social Support
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate